Upregulation of ACE/ACE2 Balance in Nasal Mucosa: A Working Hypothesis to Explain the Absence of Nasal Inflammatory Symptoms in COVID-19 Disease

Ear Nose Throat J. 2023 Oct;102(10):680-681. doi: 10.1177/01455613211025747. Epub 2021 Jun 15.

Authors

Amit Jain¹, Massimo Lamperti¹

Affiliation

¹ Anesthesiology Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates.

PMID: 34130518
DOI: 10.1177/01455613211025747

No abstract available

Keywords: COVID-19; SARS-CoV-2; epithelial–endothelial cross talk in COVID-19; nasal symptoms in COVID-19.

Publication types

Letter
Comment

MeSH terms

Angiotensin-Converting Enzyme 2
COVID-19*
Humans
Nasal Mucosa
SARS-CoV-2
Up-Regulation

Substances

Angiotensin-Converting Enzyme 2